(Q36838558)

16 August 2017

title

Do we need full compliance data for population pharmacokinetic analysis? (English)

1 reference

16 August 2017

1 reference

Girard P

1

1 reference

16 August 2017

Sheiner LB

series ordinal

2

1 reference

16 August 2017

Kastrissios H

series ordinal

3

1 reference

16 August 2017

Blaschke TF

series ordinal

4

1 reference

16 August 2017

publication date

1 June 1996

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

16 August 2017

published in

1 reference

16 August 2017

volume

24

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

265-282

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02353671

16 August 2017

exact match

0 references

cites work

Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

The estimation of population pharmacokinetic parameters using an EM algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Estimating bioavailability when clearance varies with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Designing an optimal experiment for Bayesian estimation: application to the kinetics of iodine thyroid uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Role of patient compliance in clinical pharmacokinetics. A review of recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Measurement of patient compliance and the interpretation of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Nonlinear mixed effects models for repeated measures data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

How often is medication taken as prescribed? A novel assessment technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

A pharmacokinetic perspective on medicament noncompliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Prediction of diltiazem plasma concentration curves from limited measurements using compliance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02353671

Experimental design and efficient parameter estimation in population pharmacokinetics

21 January 2018

1 reference

12 December 2020

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

12 December 2020

New strategies in drug development and clinical evaluation: the population approach. Commentary on an action for co-operative research

1 reference

12 December 2020

An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02353671

1 reference

16 August 2017

1 reference